Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chrome Holding Co.ME · Entity 76268 | Chief Administrative Officer | May 20, 2024 | May 21, 2024 |
| SOPHiA GENETICS SASOPH · Entity 5228 | Director | September 08, 2026 | September 10, 2026 |
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Director | June 18, 2026 | June 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chrome Holding Co.
Report date May 20, 2024 · Filed May 21, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 1,217,033 |
Reported balance
After 2024-05-20 transaction · row 1
1 source rowRow 1 · 2024-05-20 · Tax withholding · Disposed 35,282 · Balance 1,217,033 |
SOPHiA GENETICS SA
Report date September 08, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 96,992 |
Reported balance
After 2026-09-08 transaction · row 1
1 source rowRow 1 · 2026-09-08 · Sale · Disposed 6,250 · Balance 96,992 F1: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.35, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.35, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
STANDARD BIOTOOLS INC.
Report date June 18, 2026 · Filed June 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 236,836 |
Reported balance
After 2026-06-18 transaction · row 1
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 99,116 · Balance 236,836 F1: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| Stock Option (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.83 · Expires 2036-06-18 | Direct | 175,923 |
Reported balance
After 2026-06-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-18 · Grant · Acquired 175,923 · Balance 175,923 F2: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting.
F2: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SomaLogic, Inc.
Report date January 05, 2024 · Filed January 10, 2024
Section 16 reporting ended · disclosed 2024-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.74 · Expires 2033-06-07 | Direct | 0 |
Reported balance
After 2024-01-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-01-05 · Disposition to issuer · Disposed 185,400 · Balance 0 F2: On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the "Company") entered into the Agreement and Plan of Merger (the "Merger Agreement"), with Standard BioTools Inc., a Delaware corporation ("Parent"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the "Merger Sub"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the "Merger"); and F3: (Continued from Footnote 2) each option to purchase Company Common Stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the "Exchange Ratio") of the Parent's common stock, par value $0.001 (the "Parent Common Stock"), F4: (Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions. F1: The option vests as to 1/4th of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to 1/4th of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.
F2: On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the "Company") entered into the Agreement and Plan of Merger (the "Merger Agreement"), with Standard BioTools Inc., a Delaware corporation ("Parent"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the "Merger Sub"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the "Merger"); and
F3: (Continued from Footnote 2) each option to purchase Company Common Stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the "Exchange Ratio") of the Parent's common stock, par value $0.001 (the "Parent Common Stock"),
F4: (Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2026 Filed Sep 10, 2026 20:02 UTC | SOPHiA GENETICS SA SOPH · Entity 5228 | SaleOrdinary Shares | 6,250 | $8.13 | $50,817.50 |
DisclosureSEC source: 0001840706-26-000306 · wk-form4_1789070532.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,992 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.35, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 25, 2026 Filed Aug 26, 2026 20:04 UTC | SOPHiA GENETICS SA SOPH · Entity 5228 | SaleOrdinary Shares | 6,250 | $8.68 | $54,233.13 |
DisclosureSEC source: 0001840706-26-000301 · wk-form4_1787774686.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,242 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.31 to $8.83 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:01 UTC | SOPHiA GENETICS SA SOPH · Entity 5228 | GrantShare Option (Right to Buy) · Derivative | 28,818 | $5.46 Strike: $5.46 | $157,346.28 |
DisclosureSEC source: 0001840706-26-000223 · wk-form4_1782158500.xml · derivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,569 Underlying: Ordinary Shares · 28,818 shares Expires 2036-06-18 F2 · derivative.exercise_date: The share options were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders, subject to the Reporting Person's continued service to the Issuer through the relevant vesting date. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 20:01 UTC | SOPHiA GENETICS SA SOPH · Entity 5228 | GrantOrdinary Shares | 19,724 | $5.46 | $107,693.04 |
DisclosureSEC source: 0001840706-26-000223 · wk-form4_1782158500.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,492 F1 · shares: Represents a restricted stock unit ("RSU") grant. Each RSU represents a contingent right to receive one ordinary share of the Issuer, subject to Reporting Person's continued service with the Issuer. The RSUs were granted on June 18, 2026 and vest 100% as of the date of the Issuer's next scheduled annual meeting of shareholders. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:39 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 175,923 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001193125-26-279823 · ownership.xml · derivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,923 Underlying: Common Stock · 175,923 shares Expires 2036-06-18 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 21:39 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 99,116 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-279823 · ownership.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,836 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 18, 2027 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. Read SEC document |
| May 12, 2026 Filed May 13, 2026 20:01 UTC | SOPHiA GENETICS SA SOPH · Entity 5228 | SaleOrdinary Shares | 7,508 | $4.67 | $35,036.83 |
DisclosureSEC source: 0001840706-26-000184 · wk-form4_1778702489.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,768 F1 · shares: Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c). F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.54 to $4.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 22:55 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 125,660 | $0.00 Strike: $1.05 | $0.00 |
DisclosureSEC source: 0000950170-25-089644 · ownership.xml · derivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,660 Underlying: Common Stock · 125,660 shares Expires 2035-06-20 F2 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 20, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 22:55 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 94,592 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-089644 · ownership.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,720 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 20, 2026 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:14 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 72,213 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0000950170-24-080702 · ownership.xml · derivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,213 Underlying: Common Stock · 72,213 shares Expires 2034-06-28 F3 · derivative.exercise_date: The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 21:14 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 43,128 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-080702 · ownership.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,128 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. F2 · balance_after: The Reporting Person declined and forfeited the 79,412 RSUs previously granted to the Reporting Person on January 5, 2024 in connection with the transactions contemplated by the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc., Martis Merger Sub, Inc. and SomaLogic, Inc. Read SEC document |
| May 20, 2024 Filed May 21, 2024 16:09 UTC | Chrome Holding Co. ME · Entity 76268 | Tax withholdingClass A Common Stock | 35,282 | $0.55 | $19,285.14 |
DisclosureSEC source: 0001628280-24-024538 · wk-form4_1716322146.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217,033 Read SEC document |
| May 02, 2024 Filed May 6, 2024 16:56 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,551 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-020700 · wk-form4_1715028985.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 38,551 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| May 02, 2024 Filed May 6, 2024 16:56 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,551 | $0.49 | $19,048.05 |
DisclosureSEC source: 0001628280-24-020700 · wk-form4_1715028985.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,252,315 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.4860 to $0.5144. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 02, 2024 Filed May 6, 2024 16:56 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,551 | $0.42 | $16,191.42 |
DisclosureSEC source: 0001628280-24-020700 · wk-form4_1715028985.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,290,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 16:20 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-016955 · wk-form4_1713558012.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,551 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 16:20 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.47 | $18,148.40 |
DisclosureSEC source: 0001628280-24-016955 · wk-form4_1713558012.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,252,315 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. Read SEC document |
| April 18, 2024 Filed Apr 19, 2024 16:20 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-016955 · wk-form4_1713558012.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,290,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 16:14 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-015042 · wk-form4_1712348050.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,099 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 16:14 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.50 | $19,281.71 |
DisclosureSEC source: 0001628280-24-015042 · wk-form4_1712348050.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,252,315 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.4750 to $0.5247. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| April 04, 2024 Filed Apr 5, 2024 16:14 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-015042 · wk-form4_1712348050.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,290,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 19:22 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-012780 · wk-form4_1711149730.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,647 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 19:22 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.46 | $17,893.98 |
DisclosureSEC source: 0001628280-24-012780 · wk-form4_1711149730.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,252,315 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.4600 to $0.4748. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 21, 2024 Filed Mar 22, 2024 19:22 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-012780 · wk-form4_1711149730.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,290,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:09 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-010228 · wk-form4_1710187770.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,195 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:09 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.53 | $20,430.44 |
DisclosureSEC source: 0001628280-24-010228 · wk-form4_1710187770.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,252,315 F2 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F3 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.5035 to $0.5580. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 16:09 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-010228 · wk-form4_1710187770.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,290,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 12,488 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on February 29, 2024. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 17:09 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-006680 · wk-form4_1708726135.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,743 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 17:09 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.61 | $23,325.39 |
DisclosureSEC source: 0001628280-24-006680 · wk-form4_1708726135.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,239,827 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.5743 to $0.6570. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 17:09 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-006680 · wk-form4_1708726135.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,278,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 16:33 UTC | Chrome Holding Co. ME · Entity 76268 | Tax withholdingClass A Common Stock | 40,522 | $0.72 | $29,013.75 |
DisclosureSEC source: 0001628280-24-005921 · wk-form4_1708551147.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,239,827 Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 16:47 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-005369 · wk-form4_1708120026.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,291 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 16:47 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.78 | $30,210.07 |
DisclosureSEC source: 0001628280-24-005369 · wk-form4_1708120026.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,280,349 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.7278 to $0.8247. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 16:47 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-005369 · wk-form4_1708120026.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,318,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:24 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-002388 · wk-form4_1706318663.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,839 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:24 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.73 | $27,997.41 |
DisclosureSEC source: 0001628280-24-002388 · wk-form4_1706318663.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,280,349 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.6853 to $0.7491. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:24 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-002388 · wk-form4_1706318663.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,318,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 18:51 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001628280-24-001281 · wk-form4_1705103465.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 308,387 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 18:51 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.72 | $27,581.09 |
DisclosureSEC source: 0001628280-24-001281 · wk-form4_1705103465.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,280,349 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.6851 to $0.7430. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 11, 2024 Filed Jan 12, 2024 18:51 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001628280-24-001281 · wk-form4_1705103465.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,318,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 23:05 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantStock Option (Right to buy) · Derivative | 205,794 | Not disclosed Strike: $2.47 | Not disclosed |
DisclosureSEC source: 0001104659-24-002651 · tm242400d4_4seq1.xml · derivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,794 Underlying: Common Stock · 205,794 shares Expires 2033-06-07 F3 · price: Pursuant to the Agreement and Plan of Merger, dated October 4, 2023, by and among Standard BioTools Inc. (the "Company"), Martis Merger Sub, Inc. and SomaLogic, Inc. ("Soma Logic") (the "Merger"), each option to purchase SomaLogic common stock (a "SomaLogic Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time"), was converted into an option to acquire the number of shares of common stock of the Company equal to the product of (i) the number of shares subject to such SomaLogic Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 (the "Exchange Ratio") rounded down to the nearest whole number of shares of the Company's common stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the SomaLogic Option by the Exchange Ratio, rounded up to the nearest whole cent. F4 · price: Except as noted above, each assumed SomaLogic Option will continue to be governed by the same terms and conditions, including vesting terms and provision, as were applicable to such SomaLogic Option immediately prior to the Effective Time. F2 · derivative.exercise_date: 25% of the shares underlying the option vest on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is fully vested, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 23:05 UTC | STANDARD BIOTOOLS INC. LAB · Entity 6116 | GrantCommon Stock | 79,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-002651 · tm242400d4_4seq1.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,412 F1 · shares: Represents Restricted Stock Units ("RSUs") that vest in four equal annual installments beginning January 5, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. Read SEC document |
| January 05, 2024 Filed Jan 10, 2024 02:38 UTC | SomaLogic, Inc. SLGC · Entity 95310 | Disposition to issuerStock Option (right to buy) · Derivative | 185,400 | Not disclosed Strike: $2.74 | Not disclosed |
DisclosureSEC source: 0001209191-24-001320 · doc4.xml · derivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 185,400 shares Expires 2033-06-07 F2 · price: On October 4, 2023, SomaLogic, Inc., a Delaware corporation (the "Company") entered into the Agreement and Plan of Merger (the "Merger Agreement"), with Standard BioTools Inc., a Delaware corporation ("Parent"), and Martis Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (the "Merger Sub"). Pursuant to the Merger Agreement, on January 5, 2024, Merger Sub merged with and into the Company, with the Company surviving as a wholly-owned subsidiary of Parent (the "Merger"); and F3 · price: (Continued from Footnote 2) each option to purchase Company Common Stock (a "Company Option"), whether vested or unvested, that was outstanding immediately prior to the effective time of the Merger (the "Effective Time"), was converted into an option to acquire the number of shares of Parent Common Stock equal to the product of (i) the number of shares subject to such Company Option as of immediately prior to the Effective Time, multiplied by (ii) 1.11 shares (the "Exchange Ratio") of the Parent's common stock, par value $0.001 (the "Parent Common Stock"), F4 · price: (Continued from Footnote 3) rounded down to the nearest whole number of shares of the Parent Common Stock, at an exercise price per share equal to the quotient obtained by dividing the per share exercise price of the Company Option by the Exchange Ratio, rounded up to the nearest whole cent. Each such Company Option shall continue to have, and be subject to, the same terms and conditions applicable to such Company Option immediately prior to the Effective Time, including vesting terms and provisions. F1 · derivative.exercise_date: The option vests as to 1/4th of the total grant on June 8, 2024, and thereafter 1/36th of the total grant vests monthly until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 16:04 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001209191-23-059985 · doc4.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,935 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 16:04 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.93 | $35,903.61 |
DisclosureSEC source: 0001209191-23-059985 · doc4.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,280,349 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.8901 to $0.9593 Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 16:04 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001209191-23-059985 · doc4.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,318,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:17 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001209191-23-058956 · doc4.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 385,483 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:17 UTC | Chrome Holding Co. ME · Entity 76268 | SaleClass A Common Stock | 38,548 | $0.97 | $37,221.95 |
DisclosureSEC source: 0001209191-23-058956 · doc4.xml · nonDerivative · entry 2 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,280,349 F1 · kind: The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023. F2 · price: The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.8885 to $1.0100 Upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:17 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionClass A Common Stock | 38,548 | $0.42 | $16,190.16 |
DisclosureSEC source: 0001209191-23-058956 · doc4.xml · nonDerivative · entry 1 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,318,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2023 Filed Dec 1, 2023 16:22 UTC | Chrome Holding Co. ME · Entity 76268 | Exercise / conversionStock Option (Right to Buy) · Derivative | 38,548 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001209191-23-057070 · doc4.xml · derivative · entry 3 HIBBS KATHY L · CIK 0001267487 · Chief Administrative Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 424,031 Underlying: Class A Common Stock · 38,548 shares Expires 2024-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.